KDM1A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.057600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.887000E-01
Normal-vs-Stage2
7.813800E-01
Normal-vs-Stage3
4.487400E-01
Normal-vs-Stage4
2.705800E-01
Stage1-vs-Stage2
2.340000E-02
Stage1-vs-Stage3
5.946400E-01
Stage1-vs-Stage4
1.621350E-01
Stage2-vs-Stage3
2.890600E-01
Stage2-vs-Stage4
4.140200E-01
Stage3-vs-Stage4
1.252780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.779600E-01
Normal-vs-AfricanAmerican
8.923800E-01
Normal-vs-Asian
4.621800E-01
Caucasian-vs-AfricanAmerican
5.976800E-01
Caucasian-vs-Asian
3.485800E-02
AfricanAmerican-vs-Asian
5.318400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.853000E-01
Normal-vs-Female
8.094600E-01
Male-vs-Female
7.493800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.947400E-01
Normal-vs-Age(41-60Yrs)
5.732600E-01
Normal-vs-Age(61-80Yrs)
9.621800E-01
Normal-vs-Age(81-100Yrs)
7.569600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.757200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.580800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.623200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.847610E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.637400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.982800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.259600E-01
Normal-vs-Daily Drinker
6.032600E-01
Normal-vs-Weekly Drinker
7.809000E-01
Normal-vs-Occasional Drinker
8.571700E-02
Normal-vs-Social Drinker
7.073200E-01
Non Drinker-vs-Daily Drinker
3.601800E-02
Non Drinker-vs-Weekly Drinker
7.144800E-01
Non Drinker-vs-Occasional Drinker
3.771600E-02
Non Drinker-vs-Social Drinker
1.163810E-01
Daily Drinker-vs-Weekly Drinker
1.693800E-01
Daily Drinker-vs-Occasional Drinker
2.443000E-01
Daily Drinker-vs-Social Drinker
5.967000E-01
Weekly Drinker-vs-Occasional Drinker
5.915900E-02
Weekly Drinker-vs-Social Drinker
2.989000E-01
Occasional Drinker-vs-Social Drinker
1.455390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.795000E-01
Normal-vs-Grade 2
9.725800E-01
Normal-vs-Grade 3
9.444000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.940000E-02
Grade 1-vs-Grade 3
9.102000E-03
Grade 1-vs-Grade 4
8.795000E-01
Grade 2-vs-Grade 3
4.631800E-01
Grade 2-vs-Grade 4
9.725800E-01
Grade 3-vs-Grade 4
9.444000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.365800E-01
Normal-vs-NonDiabetic
8.219800E-01
Diabetic-vs-NonDiabetic
6.090600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.896400E-01
Normal-vs-NoPancreatitis
8.544200E-01
Pancreatitis-vs-NoPancreatitis
6.635000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.301600E-01
Normal-vs-N1
7.559800E-01
N0-vs-N1
2.579400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.535600E-03
Normal-vs-TP53-NonMutant
6.941800E-01
TP53-Mutant-vs-TP53-NonMutant
1.74679999999094E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
